Bitcoin price today: gains to $120k, near record high on U.S. regulatory cheer
CTT Pharmaceutical (TADAWUL:2070) Holdings (CTTH) CEO Ryan Khouri reported purchasing 8,000 shares of company stock on July 8, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were acquired at a price of $0.03, for a total transaction value of $240. The purchase comes as CTTH trades near its 52-week low of $0.02, with the stock down 60% over the past year. According to InvestingPro, the company currently has a market capitalization of $1.72 million and trades at a notably low Price/Book multiple. Following the transaction, Khouri directly owns 6,951,056 shares of CTT Pharmaceutical Holdings. InvestingPro analysis reveals the company maintains a FAIR Financial Health score, with 8 additional key insights available to subscribers, including detailed valuation metrics and growth indicators.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.